Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions.
Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimer's disease. The causes and consequences of tau hyperphosphorylation are routinely investigated in laboratory animals. Mice are the models of choice as they are easily amena...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094251&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850191428300308480 |
|---|---|
| author | Franck R Petry Jérôme Pelletier Alexis Bretteville Françoise Morin Frédéric Calon Sébastien S Hébert Robert A Whittington Emmanuel Planel |
| author_facet | Franck R Petry Jérôme Pelletier Alexis Bretteville Françoise Morin Frédéric Calon Sébastien S Hébert Robert A Whittington Emmanuel Planel |
| author_sort | Franck R Petry |
| collection | DOAJ |
| description | Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimer's disease. The causes and consequences of tau hyperphosphorylation are routinely investigated in laboratory animals. Mice are the models of choice as they are easily amenable to transgenic technology; consequently, their tau phosphorylation levels are frequently monitored by Western blotting using a panel of monoclonal/polyclonal anti-tau antibodies. Given that mouse secondary antibodies can recognize endogenous mouse immunoglobulins (Igs) and the possible lack of specificity with some polyclonal antibodies, non-specific signals are commonly observed. Here, we characterized the profiles of commonly used anti-tau antibodies in four different mouse models: non-transgenic mice, tau knock-out (TKO) mice, 3xTg-AD mice, and hypothermic mice, the latter a positive control for tau hyperphosphorylation. We identified 3 tau monoclonal antibody categories: type 1, characterized by high non-specificity (AT8, AT180, MC1, MC6, TG-3), type 2, demonstrating low non-specificity (AT270, CP13, CP27, Tau12, TG5), and type 3, with no non-specific signal (DA9, PHF-1, Tau1, Tau46). For polyclonal anti-tau antibodies, some displayed non-specificity (pS262, pS409) while others did not (pS199, pT205, pS396, pS404, pS422, A0024). With monoclonal antibodies, most of the interfering signal was due to endogenous Igs and could be eliminated by different techniques: i) using secondary antibodies designed to bind only non-denatured Igs, ii) preparation of a heat-stable fraction, iii) clearing Igs from the homogenates, and iv) using secondary antibodies that only bind the light chain of Igs. All of these techniques removed the non-specific signal; however, the first and the last methods were easier and more reliable. Overall, our study demonstrates a high risk of artefactual signal when performing Western blotting with routinely used anti-tau antibodies, and proposes several solutions to avoid non-specific results. We strongly recommend the use of negative (i.e., TKO) and positive (i.e., hypothermic) controls in all experiments. |
| format | Article |
| id | doaj-art-8f3ec8bfff19427f8a3f67adde728f69 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-8f3ec8bfff19427f8a3f67adde728f692025-08-20T02:14:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9425110.1371/journal.pone.0094251Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions.Franck R PetryJérôme PelletierAlexis BrettevilleFrançoise MorinFrédéric CalonSébastien S HébertRobert A WhittingtonEmmanuel PlanelAggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimer's disease. The causes and consequences of tau hyperphosphorylation are routinely investigated in laboratory animals. Mice are the models of choice as they are easily amenable to transgenic technology; consequently, their tau phosphorylation levels are frequently monitored by Western blotting using a panel of monoclonal/polyclonal anti-tau antibodies. Given that mouse secondary antibodies can recognize endogenous mouse immunoglobulins (Igs) and the possible lack of specificity with some polyclonal antibodies, non-specific signals are commonly observed. Here, we characterized the profiles of commonly used anti-tau antibodies in four different mouse models: non-transgenic mice, tau knock-out (TKO) mice, 3xTg-AD mice, and hypothermic mice, the latter a positive control for tau hyperphosphorylation. We identified 3 tau monoclonal antibody categories: type 1, characterized by high non-specificity (AT8, AT180, MC1, MC6, TG-3), type 2, demonstrating low non-specificity (AT270, CP13, CP27, Tau12, TG5), and type 3, with no non-specific signal (DA9, PHF-1, Tau1, Tau46). For polyclonal anti-tau antibodies, some displayed non-specificity (pS262, pS409) while others did not (pS199, pT205, pS396, pS404, pS422, A0024). With monoclonal antibodies, most of the interfering signal was due to endogenous Igs and could be eliminated by different techniques: i) using secondary antibodies designed to bind only non-denatured Igs, ii) preparation of a heat-stable fraction, iii) clearing Igs from the homogenates, and iv) using secondary antibodies that only bind the light chain of Igs. All of these techniques removed the non-specific signal; however, the first and the last methods were easier and more reliable. Overall, our study demonstrates a high risk of artefactual signal when performing Western blotting with routinely used anti-tau antibodies, and proposes several solutions to avoid non-specific results. We strongly recommend the use of negative (i.e., TKO) and positive (i.e., hypothermic) controls in all experiments.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094251&type=printable |
| spellingShingle | Franck R Petry Jérôme Pelletier Alexis Bretteville Françoise Morin Frédéric Calon Sébastien S Hébert Robert A Whittington Emmanuel Planel Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. PLoS ONE |
| title | Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. |
| title_full | Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. |
| title_fullStr | Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. |
| title_full_unstemmed | Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. |
| title_short | Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. |
| title_sort | specificity of anti tau antibodies when analyzing mice models of alzheimer s disease problems and solutions |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0094251&type=printable |
| work_keys_str_mv | AT franckrpetry specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT jeromepelletier specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT alexisbretteville specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT francoisemorin specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT fredericcalon specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT sebastienshebert specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT robertawhittington specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions AT emmanuelplanel specificityofantitauantibodieswhenanalyzingmicemodelsofalzheimersdiseaseproblemsandsolutions |